TAGACIT

Active Ingredients

Indications

Dyspepsia, Zollinger-ellison syndrome, Pancreatic insufficiency, Duodenal ulcer and gastric ulcer, Recurrent and stomal ulceration, Oesophageal reflux disease, Upper abdominal pain, Gastrointestinal hemorrhage, Reduce malabsorption and fluid loss in short bowel syndrome.